SCHEMBL30863419

SCHEMBL30863419

CN1CC2CN(c3ccc(C(=O)Nc4ccc(F)c5ccncc45)cc3F)CC2C1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ WDR5 P61964 7/20 0.44
▸ TRPV1 Q8NER1 1/20 0.39
▸ CYP11B1 P15538 1/20 0.38
▸ CYP11B2 P19099 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ GSK3B P49841 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ CNR1 P21554 1/20 0.37
▸ ABCB1 P08183 2/20 0.37
▸ CHRNB4 P30926 1/20 0.37
▸ CHRNA3 P32297 1/20 0.37
▸ HDAC3 O15379 1/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC2 Q92769 1/20 0.37
▸ GAA P10253 1/20 0.36
▸ BRD4 O60885 1/20 0.36
▸ JAK1 P23458 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27195719 1.00 WDR5 (0.44) WDR5TRPV1CYP11B1CYP11B2HTT
SCHEMBL27195914 0.76 HDAC3 (0.59) WDR5HDAC3BRD4
SCHEMBL27195718 0.75 HDAC1 (0.57) HDAC3HDAC1HDAC2
SCHEMBL30863472 0.75 ABCB1 (0.45) WDR5GSK3BMEN1KMT2AABCB1
SCHEMBL30863539 0.75 ABCB1 (0.45) WDR5GSK3BMEN1KMT2AABCB1
SCHEMBL30863450 0.74 TRPV1 (0.57) WDR5TRPV1MAPTCNR1GAA
SCHEMBL27195688 0.74 TRPV1 (0.57) WDR5TRPV1MAPTCNR1GAA
SCHEMBL30863422 0.73 WDR5 (0.49) WDR5MAPTMEN1KMT2AABCB1
SCHEMBL27195717 0.73 HDAC1 (0.56) HDAC3HDAC1HDAC2
Hydrochloric Acid SCHEMBL30863555 0.72 F10 (0.56) HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581017-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS Biodol Therapeutics (FR) 2025-07-09 — — EP claimed
WO-2024079072-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS BIODOL THERAPEUTICS (FR) 2024-04-18 — — WO claimed
EP-4581017-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS Biodol Therapeutics (FR) 2025-07-09 — — EP disclosed
WO-2024079072-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS BIODOL THERAPEUTICS (FR) 2024-04-18 — — WO disclosed
Send feedback